• TCM, particularly TCM injections, is widely applied in the standard treatment for hospitalized patients with respiratory diseases in China, but ADRs associated with TCM injections are worrisome.
• Nebulized TCMs, when used alone or as add-on therapy, have positive therapeutic benefits for patients with respiratory diseases.
• Nebulized TCMs lead to comparable or superior efficacy to the intravenously infused counterparts.
• Nebulized TCM treatments generally have fewer side effects than intravenously infused TCM and are free of severe ADR associated with TCM injections.
• The inhalation route may provide a viable, noninvasive, safe, and efficacious means as an alternative to TCM injections.
REFERENCES
1. World Health Organization. 2014. The top 10 causes of death. http://who.int/media- centre/factsheets/fs310/en/index.html. Accessed August 25, 2016.
2. Wang, X., Jia, W., Zhao, A. H., Wang, X. R. 2006. Anti-influenza agents from plants and traditional Chinese medicine. Phytother. Res. 20:335-341.
3. Cheng, J. Z., Zhu, H. P. 2013. The Blue Book of Medicine and Pharmaceuticals: Annual Report on China’s Pharmaceutical Market in 2012. Social Sciences Academic Press, Beijing, China.
4. Wang, L., Yuan, Q., Marshall, G., Cui, X. H., Cheng, L., Li, Y. Y., Shang, H. C., Zhang, B. L., Li Y. P. 2010. Adverse drug reactions and adverse events of 33 varieties of traditional Chinese medicine injections on National Essential medicines List (2004 edition) of China: An overview on published literatures. J. Evid. Based Med. 3:95-104.
5. Miao, X. Q., Zhou, J., Li, J., Liao, Y. H., Zheng, Y. 2015. Chinese medicine in inhalation therapy: A review of clinical application and formulation development. Curr. Pharm. Des. 21:3917-3931.
6. Sun, H. Y., Liu, M. X., Lin, Z. T., Jiang, H. X., Niu, Y. Y., Wang, H., Chen, S. Z. 2015. Comprehensive identification of 125 multifarious constituents in Shuang-huang-lian powder injection by HPLC-DAD-ESI-IT-TOF-MS. J. Pharm. Biomed. Anal. 115:86-106.
7. Li, H. W., Wu, J. F., Zhang, Z. W., Ma, Y. Y., Liao, F. F., Zhang, Y., Wu, G. J. 2011. Forsythoside a inhibits the avian infectious bronchitis virus in cell culture. Phytother. Res. 25:338-342.
8. Song, Z. J., Johansen, H. K., Moser, C., Faber, V., Kharazmi, A., Rygaard, J., Hpiby, N. 2000. Effects of Radix Angelicae sinensis and Shuanghuanglian on a rat model of chronic Pseudomonas aeruginosa pneumonia. Chin. Med. Sci. J. 15:83-88.
9. Gao, Y., Fang, L., Cai, R. L., Zong, C. J., Chen, X., Lu, J., Qi, Y. 2014. Shuang-Huang- Lian exerts anti-inflammatory and anti-oxidative activities in lipopolysaccharide- stimulated murine alveolar macrophages. Phytomedicine 21:461-469.
10. Chen, X., Howard, O. M., Yang, X., Wang, L., Oppenheim, J. J., Krakauer, T. 2002. Effects of Shuanghuanglian and Qingkailing, two multi-components of traditional Chinese medicinal preparations, on human leukocyte function. Life Sci. 70:2897-2913.
11. Zhang, H. W., Chen, Q., Zhou, W. W., Gao, S., Lin, H. G., Ye, S. F., Xu, Y. H., Cai, J. 2013. Chinese medicine injection Shuanghuanglian for treatment of acute upper respiratory tract infection: A systematic review of randomized controlled trials. Evid. Based Complement. Alternat. Med. 2013:987326.
12. Chen, W., Liu, B., Wang, L. Q., Ren, J., Liu, J. P. 2014. Chinese patent medicines for the treatment of the common cold: A systematic review of randomized clinical trials. BMC Complement Altern. Med. 14:273.
13. Zhang, H.Y., Ren, X. L., Li, Y. Z. 2010. Meta-analysis of efficacy of Shuanghuanglian for children pneumonia. Chin. Pharm. 21:4205-4208.
14. Shi, Q. P., Jiang, X. D., Ding, F., Liu, Y., Yu, M. L., Zhu, J. X., Zhang, S. Q. 2014. Consequences, measurement, and evaluation of the costs associated with adverse drug reactions among hospitalized patients in China. BMC Health Serv. Res. 14:73.
15. Wang, L., Cheng, L., Yuan, Q., Cui, X. H., Shang, H. C., Zhang, B. L., Li, Y. P. 2010. Adverse drug reactions of Shuanghuanglian injection: A systematic review of public literatures. J. Evid. Based Med. 3:18-26.
16. Wu, Y., Ren, J. T., Yan, M., Guo, X. X., Zhang, C. X., Cao, L. Y. 2004. Investigation of the clinical situation of Shuanghuanglian injection in six cities during 2001-2002. Chin. J. Pharmacovigil. 1:21-23.
17. Zhang, J. H., Shang, H. C., Zheng, W. K., Hu, J., Xu, H. J., Wang, H., Zhang, L., Ren, M., Zhang, B. L. 2010. Systematic review on the compatibility of Shuanghuanglian injection combined with western medical injections. J. Evid. Based Med. 3:27-36.
18. Yang, C. P. 2004. Observation on insoluble particles due to compatibility of Shuanghuanglian or Qingkailing injection with glucose or sodium injection. J. Henan Univ. Chin. Med. 19:18.
19. Zhai, L., Liu, Z. M., Guo, R. H., Han, G., Liu, G. J. 2007. The variations in quantity of insoluble particles of Shuanghuanglian injection after mixed with four antibiotics. Lishizhen Med. Mater. Med. Res. 18:1951-1952.
20. Liu, Z. C., Tang, Y. L. 1996. Effect of delivery routes on the clinical efficacy of Shuanghuanglian. J. Appl. Clin. Pediatr. 11:49.
21. Li, H. M., Zhang, X. M. 2007. Shuanghuanglian inhalation in treating asthmatic pneumonia of 45 cases. Chin. J. Integr. Tradit. West. Med. Intensive Crit. Care 14:302.
22. Zhang, J. J., Wu, Y. 2012. HS-GC-MS analysis of the volatile ingredients in Yuxingcao injection. J. Chin. Med. Mater. 31:1858-1860.
23. Lu, H. M., Liang, Y. Z., Qian, P. 2005. Profile-effect on quality control of Houttuynia cordata injection. Yao Xue Xue Bao 40:1147-1150.
24. Lu, H. M., Liang, Y. Z., Chen, S. 2006. Identification and quality assessment of Houttuynia cordata injection using GC-MS fingerprint: A standardization approach. J. Ethnopharmacol. 105:436-440.
25. Satthakarn, S., Hladik, F., Promsong, A., Nittayananta, W. 2015. Vaginal innate immune mediators are modulated by a water extract of Houttuynia cordata Thunb. BMC Complement. Altern. Med. 15:183.
26. Liu, F. Z., Shi, H., Shi, Y. J., Liu, Y., Jin, Y. H., Gao, Y. J., Guo, S. S., Cui, X. L. 2010. Pharmacodynamic experiment of the antivirus effect of Houttuynia cordata injection on influenza virus in mice. Yao Xue Xue Bao. 45:399-402.
27. Lu, H. M., Liang, Y. Z., Yi, L. Z., Wu, X. J. 2006. Anti-inflammatory effect of Houttuynia cordata injection. J. Ethnopharmacol. 104:245-249.
28. Lu, H. M., Wu, X. J., Liang, Y. Z., Zhang, J. 2006. Variation in chemical composition and antibacterial activities of essential oils from two species of Houttuynia Thunb. Chem. Pharm. Bull. 54:936-940.
29. Lau, K. M., Lee, K. M., Koon, C. M., Cheung, C. S., Lau, C. P., Ho, H. M., Lee, M. Y. et al. 2008. Immunomodulatory and anti-SARS activities of Houttuynia cordata. J. Ethnopharmacol. 118, 79-85.
30. Cui, X. H., Wang, L., Deng, S. L. Li, T. Q. Shang, H. C. 2011. Efficacy of Houttuynia cordata injection for respiratory system diseases: A meta-analysis. Chin. J. Evid. Based Med. 11:786-798.
31. Wang, L., Cui, X. H., Cheng, L., Yuan, Q., Li, T. Q., Li, Y. P., Deng, S. L., Shang, H. C., Bian, Z. X. 2010. Adverse events to Houttuynia injection: A systematic review. J. Evid. Based Med. 3:168-176.
32. Yi, Y., Liang, A. H., Liu, T., Zhao, Y., Cao, C. Y. 2008. Analysis of causes for adverse reaction of Yuxingcao injection. Chin. J. Chin. Mater. Med. 33:2439-2442.
33. Yuan, L. P., Ma, L. M. 2008. Aerosol inhalation of sodium houttuyfonate injection for treatment of pneumonia: A systematic review. China Pharm. 19:1652-1654.
34. Yuan, L. P., Zhou, X., Li, H. J., Wei, J. Y., Ma, L. M. 2011. Aerosol inhalation of sodium houttuyfonate injection: A systematic review. Chin. J. New Drug 20:284-292.
35. Lin, H. Y., Zeng, J., Fu, Y. P. 2001. Comparison of curative effects of herba Houttuyniae injection by spray inhalation and by intravenous drip on respiratory tract infection. Chin. Tradit. Patent. Med. 23:727-728.
36. Lan, H. Y., Huang, R. P., Huang, S. Z., Chen, Z. J., Lu, Z. S., Tan, X. L. 1998. Efficacy comparison between ultrasonic nebulized and intravenous infused Yuxingcao injection treatment of children with respiratory tract infection. J. Youjiang Med. Coll. Natl. 20:591.
37. Wang, X. L., Liu, C. Y. 1989. Efficacy comparison between ultrasonic nebulized and intramuscular dosed Yuxingcao. Hubei J. Tradit. Chin. Med. 11:22-23.
38. Zheng, X. Y. 2002. Guiding Principle of Clinical Research on New Drugs of Traditional Chinese Medicine. Chinese Medicine Science and Technology Press, Beijing, China.
39. Zhang, H. Y., Hu, P., Luo, G. A., Liang, Q. L., Wang, Y. L., Yan, S. K., Wang, Y. M. 2006. Screening and identification of multi-component in Qingkailing injection using combination of liquid chromatography/time-of-flight mass spectrometry and liquid chromatography/ion trap mass spectrometry. Anal. Chim. Acta. 577:190-200.
40. Yue, S. J., Li, Q. J., Luo, Z. Q., Tang, F., Feng, D., Deng, S., Yu, P. 2005. The neuroprotective effects and its mechanisms of Qingkailing injection on bacterial meningitis induced by E. coli in rabbits. Chin. J. Integr. Tradit. West. Med. 25:633-636.
41. Tian, Q. M., Bi, H. S., Cui, Y., Guo, D. D., Xie, X. F., Su, W. H., Wang, X. R. 2012. Qingkailing injection alleviates experimental autoimmune uveitis in rats via inhibiting Th1 and Th17 effector cells. Biol. Pharm. Bull. 35:1991-1996.
42. Li, D., Huang, J. H., Zhang, S. H., Yang, F. J. 2009. Study on anti-bacterial activity of Qingkailing freeze-dried powder for injection in vivo. Res. Prac. Chin. Med. 21:53-55.
43. Xiao, H., Gu, X., Li, L., Yang, F. J. 2009. Study on anti-viral activity of Qingkailing freeze-dried powder for injection in vivo. Pharm. Clin. Chin. Mater. Med. 25:53-54.
44. Gao, X. Y., Guo, M. X., Peng, L., Zhao, B. S., Su, J. K., Liu, H. Y., Zhang, L., Bai, X., Qiao, Y. J. 2013. UPLC Q-TOF/MS-based metabolic profiling of urine reveals the novel antipyretic mechanisms of Qingkailing injection in a rat model of yeast-induced pyrexia. Evid. Based Complement. Alternat. Med. 2013:864747.
45. Wu, J. R., Zhang, X. M., Zhang, B. 2014. Qingkailing injection for the treatment of acute stroke: A systematic review and meta-analysis. J. Tradit. Chin. Med. 34:131-139.
46. Zhang, L. G., Zhao, W. P., Yang, K. 2011. A systematic review about treating pneumonia with Qinkailing injection. Gansu J. TCM. 24:18-24.
47. Liu, Y., Lu, J. Q., Liu, Z. Q. 2010. A meta-analysis on treating respiratory system infections with Qinkailing injection. Chin. Hosp. Pharm. J. 30:519-521.
48. Zhou, Y. L., Chen, H. M., Lu, H. 2007. Systematic evaluation of adverse drug reactions of Qingkailing injection from documents. Chin. Pharm. 16:50-52.
49. Hao, Y., Kong, X. Y., Wu, T. X. 2010. Assessment of the safety of Qingkailing injection: A systematic review. Chin. J. Evid. Based Med. 10:162-175.
50. Zhang, Q. L., Wang, Z., Jin, Z. W., Yang, W. B. 2015. Study on 5800 cases of postmarketing safety intensive hospital monitoring of Qingkailing injection. Chin. J. Pharmacovigil. 12:417-423.
51. Lei, Y., Lei, J., Zhao, J. D., Chen, R. 2005. Investigation on clinical effect of Qingkailing injection for parainfluenza virus by aerosol inhalation or inject. J. Dali Univ. 4:51-53.
52. Yu, H. G., Cai, C. J. 2006. Efficacy comparison of the treatment of Qingkailing injection for pediatric respiratory system infection via different administration routes. Prac. Clin. J. Integr. Tradit. Chin. West. Med. 6:56.
53. Sun, L., Wei, H., Zhang, F., Gao, S. H., Zeng, Q. H., Lu, W. Q., Chen, W. S., Chai, Y. F. 2013. Qualitative analysis and quality control of traditional Chinese medicine preparation Tanreqing injection by LC-TOF/MS and HPLC-DAD-ELSD. Anal. Methods 5:6431-6440.
54. Zhu, L. Q., Bai, M., Li, J. Y., Xu, Y. G., Gao, Z. Y. 2008. Meta-analysis of the efficacy Tanreqing injection on infections of respiratory system. Chin. Hosp. Pharm. J. 28:464-467.
55. Zhong, Y. Q., Mao, B., Wang, G., Fan, T., Liu, X. M., Diao, X., Fu, J. J. 2010. Tanreqing injection combined with conventional Western medicine for acute exacerbations of chronic obstructive pulmonary disease: A systematic review. J. Altern. Complement. Med. 16(12): 1309-1319.
56. Jiang, H. L., Mao, B., Zhong, Y. Q., Yang, H. M., Fu, J. J. 2009. Tanreqing injection for community-acquired pneumonia: A systematic review of randomized evidence. J. Chin. Integr. Med. 7:9-19.
57. Li, Y. H., Zhu, H. J. 2011. Systematic assessment on randomized controlled trials for treatment of acute exacerbation of chronic obstructive pulmonary disease by Tanreqing injection. Prac. Pharm. Clin. Remed. 14:281-285.
58. Tang, Q. L., Sun, Y. X., Kang, A. R., Li, K. Q., Lu, C. X. 2015. Analysis of clinical application of Tanreqing injection in children based on real world research. Chin. J. Hosp. Pharm. 16:1488-1490.
59. Yang, X. F., Dong, Z., Lu, X. Q., Zhu, S. B. 2015. Analysis of 376 adverse drug reactions of Tanreqing injection in Chongqing. Chin. J. New Drugs Clin. Rem. 34:239-242.
60. Zhang, Y., Yang, Y. H., Liu, F., Zhai, S. D. 2010. Aerosol inhalation of Tanreqing injection in the treatment of respiratory system diseases: A systematic review. Eval. Anal. Drug Use Hosp. Chin. 10:483-487.
61. Li, Y. F., Ren, H. X., Zhang, W., Zhuang, S. N., Wang, D., Wang, X. X., Wang, J., Wang, H. C., Wang, J. Y., Zhao, L. P. 2015. Effect of nebulized Tanreqing injection on the inflammation of patients with acute exacerbation chronic obstructive pulmonary diseases. Ningxia Med. J. 37:555-557.
62. Nong, D. M., Jiang, F. Z., Wu, X. L., Huang, S. Q., Hu, X. D., Liu, R. S. 2009. The clinical effects of bronchiolitis treated by Tanreqing injection in different ways. Chin. Modern Doc. 47:34-35.
63. Zou, S. Y., Gu, X. Y. 2013. Efficacy of Tanreqing injection in different administration routes in the treatment of bronchitis. Chin. J. Pharm. Econom. 8:243-244.
64. Jarukamjorn, K., Nemoto, N. 2008. Pharmacological aspects of Andrographis panicu- lata on health and its major diterpenoids constituent andrographolide. J. Health Sci. 54:370-381.
65. Kumar, R. A., Sridevi, K., Kumar, N. V., Nanduri, S., Rajagopal, S. 2004. Anticancer and immunostimulatory compounds from Andrographis paniculata. J. Ethnopharmacol. 92:291-295.
66. Jayakumar, T., Hsieh, C. Y., Lee, J. J., Sheu, J. R. 2013. Experimental and clinical pharmacology of Andrographis paniculata and its major bioactive phytoconstituent andrographolide. Evid. Based Complement. Alternat. Med. 2013:846740.
67. Sun, S. G., Shi, Y. F., Li, Y., Wang, R., Wang, S. H., Sun, X. D. 2015. Xiyanping injection in treatment of viral pneumonia in children: A meta-analysis of random control trials. Chin. Herb. Med. 7:173-178.
68. Liu, L., Jiang, D., Chen, F., Xu, W. F., Du, X. H., Sun, Q. R., Jia, P. 2013. The efficacy and safety of Xiyanping injection in treating bronchiolitis: A systematic review. West Chin. J. Pharm. Sci. 28:650-652.
69. China Food and Drug Administration. 2011. Adverse Drug Reaction Information Bulletin. http://www.sda.gov.cn/WS01/CL0078/72891.html. Accessed August 25, 2016.
70. Wang, Y. P., Jiao, K., He, Z. F. 2011. Systematic evaluation of adverse drug reactions of Xiyanping injection from documents. Chin. J. Exp. Tradit. Med. Form. 17:236-239.
71. Yang, H. G. 2014. Clinical observation of the treatment of pediatric respiratory tract infection in 500 children. Chin. Health Ind. 35:129-130.
72. Geng, L., Fang, B. X., Chen, S. M., Zhu, J., Li, P. 2014. Meta-analysis of different administrative route of Xiyanping injection for treating respiratory tract infection in children. Modern J. Integr. Tradit. Chin. West. Med. 23:3214-3216.
73. Liu, G. F., Zou, Y. F., Liu, G. H., Bai, J. R., Zhang, Y. F., Zhang, X. Y. 2013. The efficacy of radioactive pneumonia treated by Lianbizhi injection in intravenous and inhalation for adjuvant therapy. Hebei Med. J. 35:854-855.
74. Liu, A. H., Lin, Y. H., Yang, M., Guo, H., Guan, S. H., Sun, J. H., Guo, D. A. 2007. Development of the fingerprints for the quality of the roots of Salvia miltiorrhiza and its related preparations by HPLC-DAD and LC-MSn. J. Chromatogr. B. 846:32-41.
75. China Food and Drug Administration. 2012. Adverse Drug Reaction Information Bulletin. http://www.sda.gov.cn/WS01/CL0078/70155.html. Accessed August 25, 2016.
76. The United Nations Environment Programme. 2012. Report of the technology and economic assessment panel. http://ozone.unep.org/Assessment_Panels/TEAP/Reports/ TEAP_Reports/teap-progress-report-may2012.pdf. Accessed August 25, 2016.
77. Wang, Y. H., Xu, K. J., Jiang, W. S., Lu, F. Z., Hu, M. Y., Zhe, Z. K., Gao, F., Zhang, J. W., He, X. L., Hong, F. Y. 1996. Clinical and experimental study on treatment of acute respiratory tract infection with Shuanghuanglian Aerosol. Chin. J. Integr. Tradit. West. Med. 2:162-165.
78. Yang, J. J., Liu, C. Y., Quan, L. H., Liao, Y. H. 2012. Preparation and in vitro aerosol performance of spray-dried Shuang-Huang-Lian corrugated particles in carrier-based dry powder inhalers. AAPS PharmSciTech. 13:816-825.
79. Han, R., Ye, J. X., Quan, L. H., Liu, C. Y., Liao, Y. H. 2011. Evaluating pulmonary toxicity of Shuanghuanglian in vitro and in vivo. J. Ethnopharmacol. 135:522-529.
80. Ma, Z. Q., Lu, J. J., Xu, W. S., Chen, X. P., Hu, H., Wang, Y. T. 2013. Analysis of traditional Chinese medicine injections used in the treatment of respiratory system- related diseases based on the Chinese market. Global J. Res. Med. Plant. Indigen. Med. 2:499-508.
81. Ye, J. X., Wang, W., Quan, L. H., Liu, C. Y., Liao, Y. H. 2010. An LC-MS/MS method for the simultaneous determination of chlorogenic acid, forsythiaside A and baicalin in rat plasma and its application to pharmacokinetic study of Shuang-huang-lian in rats. J. Pharm. Biomed. Anal. 52:625-630.
Found a mistake? Please highlight the word and press Shift + Enter